Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 236842, 6 pages
http://dx.doi.org/10.1155/2014/236842
Clinical Study

The Role of Disease Activity Score 28 in the Evaluation of Articular Involvement in Systemic Lupus Erythematosus

Lupus Clinic, Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Viale del Policlinico 155, 00161 Roma, Italy

Received 29 July 2014; Accepted 29 September 2014; Published 3 November 2014

Academic Editor: Klaus Tenbrock

Copyright © 2014 Fulvia Ceccarelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. A. Ball and A. L. Bell, “Lupus arthritis-do we have a clinically useful classification?” Rheumatology, vol. 51, pp. 771–779, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Iagnocco, A. Ossandon, G. Coari et al., “Wrist joint involvement in systematic lupus erythematosus. An ultrasonographic study,” Clinical and Experimental Rheumatology, vol. 22, no. 5, pp. 621–624, 2004. View at Google Scholar · View at Scopus
  3. A. Ossandon, A. Iagnocco, C. Alessandri, R. Priori, F. Conti, and G. Valesini, “Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 27, no. 2, pp. 329–332, 2009. View at Google Scholar · View at Scopus
  4. A. Iagnocco, F. Ceccarelli, C. Rizzo et al., “Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus,” Rheumatology, vol. 53, no. 3, Article ID ket376, pp. 465–472, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. D. D. Gladman, D. Ibañez, and M. B. Urowltz, “Systemic lupus erythematosus disease activity index 2000,” Journal of Rheumatology, vol. 29, no. 2, pp. 288–291, 2002. View at Google Scholar · View at Scopus
  6. M. L. L. Prevoo, M. A. van 'T Hof, H. H. Kuper, M. A. van Leeuwen, L. B. A. van de Putte, and P. L. C. M. van Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Fransen, M. C. W. Creemers, and P. L. C. M. Van Riel, “Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria,” Rheumatology, vol. 43, no. 10, pp. 1252–1255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Salaffi, A. Ciapetti, M. Carotti, S. Gasparini, and M. Gutierrez, “Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world,” BioMed Research International, vol. 2014, Article ID 528105, 12 pages, 2014. View at Publisher · View at Google Scholar
  9. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 40, no. 9, p. 1725, 1997. View at Google Scholar · View at Scopus
  10. D. Aletaha, T. Neogi, A. J. Silman et al., “2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Arthritis and Rheumatism, vol. 62, no. 9, pp. 2569–2581, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Pengo, A. Tripodi, G. Reber et al., “Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis,” Journal of Thrombosis and Haemostasis, vol. 7, no. 10, pp. 1737–1740, 2009. View at Publisher · View at Google Scholar
  12. L. Lisnevskaia, G. Murphy, and D. Isenberg, “Systemic lupus erythematosus,” The Lancet, vol. 29, 2014. View at Publisher · View at Google Scholar
  13. T. Colasanti, A. Maselli, F. Conti et al., “Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 64, no. 3, pp. 778–787, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Alessandri, C. Barbati, D. Vacirca et al., “T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy,” FASEB Journal, vol. 26, no. 11, pp. 4722–4732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Valesini, C. Alessandri, D. Celestino, and F. Conti, “Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus,” Annals of the New York Academy of Sciences, vol. 1069, pp. 118–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Conti, F. R. Spinelli, C. Alessandri, and G. Valesini, “Toll-like receptors and lupus nephritis,” Clinical Reviews in Allergy and Immunology, vol. 40, no. 3, pp. 192–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Govoni, S. Bombardieri, A. Bortoluzzi et al., “Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 italian patients,” Rheumatology, vol. 51, Article ID ker310, pp. 157–168, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Conti, F. Ceccarelli, C. Perricone et al., “Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus : a 2-year follow-up study,” PLoS ONE, vol. 7, no. 9, Article ID e45934, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-S. Yee, V. Farewell, D. A. Isenberg et al., “British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 56, no. 12, pp. 4113–4119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Smolen and D. Aletaha, “The assessment of disease activity in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 28, no. 3, pp. S18–S27, 2010. View at Google Scholar · View at Scopus
  21. M. N. Islam, M. Hossain, S. A. Haq, M. N. Alam, P. M. Ten Klooster, and J. J. Rasker, “Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus,” International Journal of Rheumatic Diseases, vol. 15, no. 1, pp. 62–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Castrejõn, Y. Yazici, and T. Pincus, “Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis,” Arthritis Care & Research, vol. 65, no. 2, pp. 288–293, 2013. View at Publisher · View at Google Scholar · View at Scopus